Inspiratory Muscle Training in Hypercapnic COPD

Sponsor
Krankenhaus Kloster Grafschaft (Other)
Overall Status
Unknown status
CT.gov ID
NCT00291460
Collaborator
(none)
40
1
24.9
1.6

Study Details

Study Description

Brief Summary

The trial intends to investigate, whether inspiratory muscle training in hypercapnic patients improves inspiratory muscle strength, inspiratory muscle endurance and endurance to walk within six minutes.

Condition or Disease Intervention/Treatment Phase
  • Device: inspiratory muscle training
Phase 4

Detailed Description

Inspiratory muscle training is known to improve inspiratory muscle strength, inspiratory muscle endurance and walking distance within six minutes in patients with neuromuscular and thoraco-restrictive disease as well as in patients with COPD. Studies have only been conducted in patients without established respiratory failure. COPD patients with respiratory failure though are characterized by higher work rates of the inspiratory muscles and higher esophageal pressure swings compared to non-hypercapnic patients indication a discrepancy between muscle load and muscle capabilities. Therefore we hypothesize that for these patients training of their inspiratory muscles will be of benefit in terms of improvement of muscular and whole body endurance.

During this investigation inspiratory muscle training will be applied in a randomized controlled fashion in 40 patients over a period of four weeks parallel to physical rehabilitation.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single
Primary Purpose:
Treatment
Official Title:
Randomized Controlled Trial of Inspiratory Muscle Training in Patients With Stable Hypercapnic Respiratory Failure Due to COPD
Study Start Date :
Feb 1, 2006
Study Completion Date :
Mar 1, 2008

Outcome Measures

Primary Outcome Measures

  1. inspiratory muscle strength []

  2. inspiratory muscle endurance []

  3. walking distance with dyspnea score []

  4. Carbon dioxide level []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • COPD with FEV1/FVC < 70 %

  • age > 18

  • stable disease

  • able to walk

  • carbon dioxide >= 48 mmHg

Exclusion Criteria:
  • ejection fraction of the heart < 40 %

  • active psychiatric disease

  • bronchial hyperresponsiveness according to ATS criteria

  • pregnancy

  • renal insufficiency with a creatinine < 2 mg/dl

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fachkrankenhaus Kloster Grafschaft Schmallenberg Germany 57392

Sponsors and Collaborators

  • Krankenhaus Kloster Grafschaft

Investigators

  • Principal Investigator: Dominic Dellweg, M.D., FKKG
  • Study Chair: Dieter Koehler, Prof. Dr., FKKG

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00291460
Other Study ID Numbers:
  • FKKG IMT 0106
First Posted:
Feb 14, 2006
Last Update Posted:
Aug 21, 2006
Last Verified:
Feb 1, 2006

Study Results

No Results Posted as of Aug 21, 2006